£520.00

It has never been this cheap. We have no record of a lower price.

£520 today · cheaper than every other day in the last 3 months

Hepatitis B Vaccine Outlook 2023-2028 - US Market Study

View at Amazon

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 14 days · 14 data points (no recent data)

Historical
Generating forecast…
£520.00 £494.00 £504.40 £514.80 £525.20 £535.60 £546.00 03 August 2026 06 August 2026 09 August 2026 12 August 2026 16 August 2026
View at Amazon ↗

Price data last checked 77 day(s) ago - refreshing...

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↑ Price chart
when this has been cheap or pricey
↑ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price Distribution

Price distribution over 14 days • 1 price levels

Days at Price
14 days 0 4 7 11 14 £520 Days at Price

Price Analysis

Most common price: £520 (14 days, 100.0%)

Price range: £520 - £520

Price levels: 1 different prices over 14 days

Description

This market study provides a comprehensive look at the latent demand for hepatitis B vaccines across the United States from 2023 to 2028. By utilizing econometric models, the report delivers potential industry earnings (P.I.E.) estimates in millions of U.S. dollars. Data is distributed across approximately 12,600 cities, offering a granular view of market opportunities. For every city analyzed, the report provides the percent share relative to both the state and the entire United States. These comparative benchmarks allow users to evaluate specific cities against others quickly. This statistical approach provides a foundation for developing effective distribution and sales force strategies based on localized demand trends.

Key Features

Provides latent demand outlook for hepatitis B vaccines across US states and cities through 2028.

Includes potential industry earnings (P.I.E.) estimates in millions of U.S. dollars for 12,600 cities.

Offers comparative benchmarks by reporting the percent share of each city relative to its state and the nation.

Uses econometric models to deliver statistical data for distribution and sales force strategy development.

Covers a vast geographic scope including detailed city-level data across the United States.

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
26 October 2022
Listed Since
10 November 2022

Similar Products You Might Like

The 2023-2028 Outlook for Hepatitis B Vaccines in China
99% match

The 2023-2028 Outlook for Hepatitis B Vaccines in China

£495.00 20 Aug 2026
The 2023-2028 World Outlook for Hepatitis B Vaccines
99% match

The 2023-2028 World Outlook for Hepatitis B Vaccines

Price unavailable
The 2023-2028 Outlook for Hepatitis B Vaccines in Japan
99% match

The 2023-2028 Outlook for Hepatitis B Vaccines in Japan

£495.00 28 Oct 2026
The 2025-2030 World Outlook for Hepatitis B Vaccines
99% match

The 2025-2030 World Outlook for Hepatitis B Vaccines

Price unavailable
Hepatitis B Diagnostic Test Outlook in India 2023-2028
99% match

Hepatitis B Diagnostic Test Outlook in India 2023-2028

£515.00 19 Aug 2026
The 2023-2028 World Outlook for Mono Hepatitis B Vaccines
98% match

The 2023-2028 World Outlook for Mono Hepatitis B Vaccines

£795.00 12 Sep 2026
The 2023-2028 World Outlook for Hepatitis B Diagnostic Tests
98% match

The 2023-2028 World Outlook for Hepatitis B Diagnostic Tests

Price unavailable
Hepatitis B Vaccine Outlook 2023-2028 - US Zip Code Study
98% match

Hepatitis B Vaccine Outlook 2023-2028 - US Zip Code Study

£490.00 24 Aug 2026
The 2023-2028 Outlook for Hepatitis B Diagnostic Tests in China
98% match

The 2023-2028 Outlook for Hepatitis B Diagnostic Tests in China

£495.00 19 Aug 2026
The 2025-2030 World Outlook for Mono Hepatitis B Vaccines
98% match

The 2025-2030 World Outlook for Mono Hepatitis B Vaccines

Price unavailable
The 2023-2028 Outlook for Hepatitis B Diagnostic Tests in Japan
98% match

The 2023-2028 Outlook for Hepatitis B Diagnostic Tests in Japan

£495.00 25 Aug 2026
Hepatitis B Diagnostic Test Outlook 2023-2028 - US Study
97% match

Hepatitis B Diagnostic Test Outlook 2023-2028 - US Study

£490.00 20 Aug 2026
The 2023-2028 Outlook for Viral Hepatitis and Retrovirus Diagnostic Tests in Japan
97% match

The 2023-2028 Outlook for Viral Hepatitis and Retrovirus Diagnostic Tests in Japan

£495.00 28 Aug 2026
The 2016-2021 Outlook for Hepatitis C Virus (HCV) Therapeutics in Greater China
97% match

The 2016-2021 Outlook for Hepatitis C Virus (HCV) Therapeutics in Greater China

£595.00 26 Aug 2026
The 2023-2028 Outlook for Plant-Based Vaccines in India
97% match

The 2023-2028 Outlook for Plant-Based Vaccines in India

£515.00 28 Oct 2026
The 2013-2018 Outlook for Hepatitis C Virus (HCV) Therapeutics in India
97% match

The 2013-2018 Outlook for Hepatitis C Virus (HCV) Therapeutics in India

£495.00 31 Oct 2026
Hepatitis B Virus - Pathogenesis and Therapeutic Approaches
97% match

Hepatitis B Virus - Pathogenesis and Therapeutic Approaches

IntechOpen

£119.00 19 Sep 2026
The 2016-2021 Outlook for Hepatitis C Virus (HCV) Therapeutics in the United States
97% match

The 2016-2021 Outlook for Hepatitis C Virus (HCV) Therapeutics in the United States

£595.00 28 Oct 2026
The 2025-2030 World Outlook for Viral Hepatitis and Retrovirus Diagnostic Tests
97% match

The 2025-2030 World Outlook for Viral Hepatitis and Retrovirus Diagnostic Tests

Price unavailable
Hepatitis B Virus: Methods and Protocols (Methods in Molecular Biology, 2837)
97% match

Hepatitis B Virus: Methods and Protocols (Methods in Molecular Biology, 2837)

Humana

£120.83 24 Sep 2026
Elimination of Viral Hepatitis B and C - Global Initiatives, National Programs, and Scientific Advances
97% match

Elimination of Viral Hepatitis B and C - Global Initiatives, National Programs, and Scientific Advances

IntechOpen

£114.00 03 Oct 2026
The 2023-2028 Outlook for COVID-19 Vaccines in the United States
96% match

The 2023-2028 Outlook for COVID-19 Vaccines in the United States

£520.00 18 Aug 2026
Hepatitis B Virus: Methods and Protocols: 2837 (Methods in Molecular Biology, 2837)
96% match

Hepatitis B Virus: Methods and Protocols: 2837 (Methods in Molecular Biology, 2837)

Humana

£121.25 15 Aug 2026
The 2025-2030 World Outlook for Hepatitis C Therapies
96% match

The 2025-2030 World Outlook for Hepatitis C Therapies

Price unavailable